Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 3
2000 1
2001 4
2002 3
2003 1
2004 3
2005 2
2006 1
2007 1
2008 1
2009 2
2010 1
2011 1
2012 1
2013 3
2014 2
2015 4
2016 3
2017 3
2018 3
2019 5
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Results by year
Filters applied: . Clear all
Page 1
Past, Present, and Future of Drug-Drug Interactions.
Levy RH, Ragueneau-Majlessi I. Levy RH, et al. Among authors: ragueneau majlessi i. Clin Pharmacol Ther. 2019 Jun;105(6):1286-1288. doi: 10.1002/cpt.1349. Epub 2019 Feb 17. Clin Pharmacol Ther. 2019. PMID: 30773619 Review. No abstract available.
Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017.
Yu J, Petrie ID, Levy RH, Ragueneau-Majlessi I. Yu J, et al. Among authors: ragueneau majlessi i. Drug Metab Dispos. 2019 Feb;47(2):135-144. doi: 10.1124/dmd.118.084905. Epub 2018 Nov 15. Drug Metab Dispos. 2019. PMID: 30442649 Review.
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.
Sager JE, Yu J, Ragueneau-Majlessi I, Isoherranen N. Sager JE, et al. Among authors: ragueneau majlessi i. Drug Metab Dispos. 2015 Nov;43(11):1823-37. doi: 10.1124/dmd.115.065920. Epub 2015 Aug 21. Drug Metab Dispos. 2015. PMID: 26296709 Free PMC article. Review.
Evaluation of various static in vitro-in vivo extrapolation models for risk assessment of the CYP3A inhibition potential of an investigational drug.
Vieira ML, Kirby B, Ragueneau-Majlessi I, Galetin A, Chien JY, Einolf HJ, Fahmi OA, Fischer V, Fretland A, Grime K, Hall SD, Higgs R, Plowchalk D, Riley R, Seibert E, Skordos K, Snoeys J, Venkatakrishnan K, Waterhouse T, Obach RS, Berglund EG, Zhang L, Zhao P, Reynolds KS, Huang SM. Vieira ML, et al. Among authors: ragueneau majlessi i. Clin Pharmacol Ther. 2014 Feb;95(2):189-98. doi: 10.1038/clpt.2013.187. Epub 2013 Sep 18. Clin Pharmacol Ther. 2014. PMID: 24048277
Drug-Drug Interactions of Infectious Disease Treatments in Low-Income Countries: A Neglected Topic?
McFeely SJ, Yu J, Zhao P, Hershenson S, Kern S, Ragueneau-Majlessi I, Hartman D. McFeely SJ, et al. Among authors: ragueneau majlessi i. Clin Pharmacol Ther. 2019 Jun;105(6):1378-1385. doi: 10.1002/cpt.1397. Epub 2019 Mar 21. Clin Pharmacol Ther. 2019. PMID: 30771252 Free PMC article. Review.
Inhibitors of Organic Anion-Transporting Polypeptides 1B1 and 1B3: Clinical Relevance and Regulatory Perspective.
McFeely SJ, Ritchie TK, Yu J, Nordmark A, Berglund EG, Levy RH, Ragueneau-Majlessi I. McFeely SJ, et al. Among authors: ragueneau majlessi i. J Clin Pharmacol. 2020 Aug;60(8):1087-1098. doi: 10.1002/jcph.1604. Epub 2020 Mar 20. J Clin Pharmacol. 2020. PMID: 32196692
Identification and Evaluation of Clinical Substrates of Organic Anion Transporting Polypeptides 1B1 and 1B3.
McFeely SJ, Ritchie TK, Yu J, Nordmark A, Levy RH, Ragueneau-Majlessi I. McFeely SJ, et al. Among authors: ragueneau majlessi i. Clin Transl Sci. 2019 Jul;12(4):379-387. doi: 10.1111/cts.12623. Epub 2019 Mar 12. Clin Transl Sci. 2019. PMID: 30706983 Free PMC article.
Variability in In Vitro OATP1B1/1B3 Inhibition Data: Impact of Incubation Conditions on Variability and Subsequent Drug Interaction Predictions.
McFeely SJ, Ritchie TK, Ragueneau-Majlessi I. McFeely SJ, et al. Among authors: ragueneau majlessi i. Clin Transl Sci. 2020 Jan;13(1):47-52. doi: 10.1111/cts.12691. Epub 2019 Sep 28. Clin Transl Sci. 2020. PMID: 31468718 Free PMC article.
Key Findings from Preclinical and Clinical Drug Interaction Studies Presented in New Drug and Biological License Applications Approved by the Food and Drug Administration in 2014.
Yu J, Ritchie TK, Zhou Z, Ragueneau-Majlessi I. Yu J, et al. Among authors: ragueneau majlessi i. Drug Metab Dispos. 2016 Jan;44(1):83-101. doi: 10.1124/dmd.115.066720. Epub 2015 Sep 30. Drug Metab Dispos. 2016. PMID: 26424199 Review.
Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings.
Yu J, Zhou Z, Tay-Sontheimer J, Levy RH, Ragueneau-Majlessi I. Yu J, et al. Among authors: ragueneau majlessi i. J Pharm Sci. 2017 Sep;106(9):2312-2325. doi: 10.1016/j.xphs.2017.04.004. Epub 2017 Apr 13. J Pharm Sci. 2017. PMID: 28414144 Review.
48 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback